Details

Autor(en) / Beteiligte

• TISHLER, R. B
• GEARD, C. R
• HALL, E. J
• SCHIFF, P. B

Titel

Taxol sensitizes human astrocytoma cells to radiation

Ist Teil von

• Cancer research (Chicago, Ill.), 1992-06, Vol.52 (12), p.3495-3497

Ort / Verlag

Philadelphia, PA: American Association for Cancer Research

Erscheinungsjahr

1992

Quelle

MEDLINE

Beschreibungen/Notizen

• Taxol is a chemotherapeutic drug which acts by stabilizing microtubules, preventing normal mitosis and resulting in a block of the cell cycle at G2 and M. The drug is isolated from the yew, Taxus sp. L., and is currently being evaluated in a series of Phase II and Phase III clinical trials. Taxol blocks cells in the most radiosensitive phases of the cell cycle and thus could act as a cell cycle-specific radiosensitizer. We report the results of combined taxol-radiation exposures in the human Grade III astrocytoma cell line, G18. Taxol is a potent inhibitor of G18 cell division; a concentration of 10 nM is cytostatic for a cell population observed for at least two doubling times. Cell survival curves for G18 cells showed a significant concentration-dependent interaction between taxol and radiation. Treatment of G18 cells with a fixed taxol concentration and radiation dose showed the interaction to be dependent on the duration of taxol exposure and consequently the fraction of cells in the G2 or M phase of the cell cycle. The sensitizer enhancement ratio for 10 nM taxol at 10% survival is 1.8 and, for 1 nM taxol, it is 1.2. These results suggest that appropriate combinations of taxol have a more than additive interaction in human tissue culture and may have a role in clinical protocols.